These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Treatment of sudden hearing loss through Fibrinogen/LDL-apheresis. A prospective, randomized multicenter trial]. Suckfüll M, Seidel D, Thiery J, Mazurek B, Jaehne M, Gronemeyer J, Reichel O, Sasama J, Kichigina S, Möller M, Beil FU, Schrameyer-Wernecke A, Kassner U, Koch M, Jaeger B, Osterkorn K, Osterkorn D. Z Kardiol; 2003 Nov; 92(Suppl 3):III59-63. PubMed ID: 14663604 [Abstract] [Full Text] [Related]
6. Improved treatment of sudden hearing loss by specific fibrinogen aphaeresis. Ullrich H, Kleinjung T, Steffens T, Jacob P, Schmitz G, Strutz J. J Clin Apher; 2004 Nov; 19(2):71-8. PubMed ID: 15274199 [Abstract] [Full Text] [Related]
9. Does a reduction of adhesion molecules by LDL-apheresis have a role in the treatment of sudden hearing loss? Ramunni A, Quaranta N, Saliani MT, Fallacara RA, Ria R, Ranieri G. Ther Apher Dial; 2006 Jun; 10(3):282-6. PubMed ID: 16817795 [Abstract] [Full Text] [Related]
16. [Hemorheological disorders in patients with sudden deafness]. Zheng S, Jiang R, Fan M. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 1997 Mar; 14(1):11-4, 57. PubMed ID: 9817657 [Abstract] [Full Text] [Related]
17. Changes in myocardial vasoreactivity after drastic reduction of plasma fibrinogen and cholesterol: a clinical study in long-term heart transplant survivors using positron emission tomography. Jaeger BR, Bengel FM, Odaka K, Uberfuhr P, Labarrere CA, Bengsch S, Engelschalk C, Kreuzer E, Reichart B, Schwaiger M, Seidel D. J Heart Lung Transplant; 2005 Dec; 24(12):2022-30. PubMed ID: 16364844 [Abstract] [Full Text] [Related]
18. [Blood viscosity disorders as an etiopathological factor in sudden deafness]. García Callejo FJ, Velert Vila MM, Orts Alborch MH, Pardo Mateu L, Monzó Gandía R, Marco Algarra J. Acta Otorrinolaringol Esp; 1997 Oct; 48(7):517-22. PubMed ID: 9489151 [Abstract] [Full Text] [Related]
19. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS). Tsuchida H, Shigematsu H, Ishimaru S, Iwai T, Akaba N, Umezu S. Int Angiol; 2006 Sep; 25(3):287-92. PubMed ID: 16878078 [Abstract] [Full Text] [Related]